Concepts (297)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Folding | 28 | 2022 | 127 | 6.930 |
Why?
|
| Quantum Dots | 5 | 2024 | 30 | 4.390 |
Why?
|
| Disulfides | 20 | 2022 | 77 | 4.370 |
Why?
|
| Ribonuclease, Pancreatic | 20 | 2022 | 27 | 3.760 |
Why?
|
| Proteins | 10 | 2022 | 369 | 3.290 |
Why?
|
| Neurodegenerative Diseases | 6 | 2024 | 131 | 2.640 |
Why?
|
| Nanoparticles | 6 | 2024 | 318 | 2.410 |
Why?
|
| Carbon | 5 | 2024 | 105 | 2.330 |
Why?
|
| Muramidase | 2 | 2024 | 22 | 1.910 |
Why?
|
| Lactoglobulins | 2 | 2024 | 11 | 1.910 |
Why?
|
| Endoplasmic Reticulum | 5 | 2018 | 105 | 1.780 |
Why?
|
| alpha-Synuclein | 4 | 2022 | 52 | 1.690 |
Why?
|
| Amyloid | 3 | 2022 | 54 | 1.580 |
Why?
|
| Protein Disulfide-Isomerases | 4 | 2014 | 12 | 1.540 |
Why?
|
| Reactive Oxygen Species | 9 | 2024 | 461 | 1.490 |
Why?
|
| Oxidative Stress | 5 | 2022 | 938 | 1.340 |
Why?
|
| Ellagic Acid | 2 | 2020 | 4 | 1.230 |
Why?
|
| Amyloidosis | 3 | 2022 | 33 | 1.190 |
Why?
|
| Oxidation-Reduction | 20 | 2022 | 431 | 1.190 |
Why?
|
| Apoptosis | 7 | 2024 | 1398 | 1.160 |
Why?
|
| Nanostructures | 4 | 2022 | 134 | 1.160 |
Why?
|
| Animals | 36 | 2024 | 15081 | 1.120 |
Why?
|
| Carrier Proteins | 4 | 2016 | 305 | 1.040 |
Why?
|
| Nerve Tissue Proteins | 4 | 2016 | 360 | 1.010 |
Why?
|
| Rotenone | 4 | 2020 | 19 | 0.990 |
Why?
|
| Curcumin | 3 | 2010 | 74 | 0.980 |
Why?
|
| Caprylates | 1 | 2024 | 11 | 0.960 |
Why?
|
| Fluorocarbons | 1 | 2024 | 26 | 0.930 |
Why?
|
| Caffeic Acids | 1 | 2023 | 3 | 0.930 |
Why?
|
| Neuroblastoma | 2 | 2022 | 129 | 0.920 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 78 | 0.910 |
Why?
|
| Cattle | 17 | 2022 | 477 | 0.900 |
Why?
|
| Graphite | 1 | 2024 | 51 | 0.900 |
Why?
|
| Kinetics | 12 | 2022 | 708 | 0.880 |
Why?
|
| Humans | 32 | 2024 | 37093 | 0.830 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2022 | 35 | 0.820 |
Why?
|
| Herbicides | 1 | 2022 | 44 | 0.810 |
Why?
|
| Nanotechnology | 2 | 2020 | 153 | 0.780 |
Why?
|
| Protein Conformation | 10 | 2021 | 389 | 0.760 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 7 | 0.760 |
Why?
|
| Alanine | 1 | 2020 | 30 | 0.760 |
Why?
|
| Drug Discovery | 3 | 2018 | 82 | 0.750 |
Why?
|
| Fullerenes | 1 | 2021 | 31 | 0.750 |
Why?
|
| Nanotubes, Carbon | 1 | 2021 | 79 | 0.700 |
Why?
|
| Protein Transport | 4 | 2017 | 302 | 0.690 |
Why?
|
| Microscopy, Atomic Force | 1 | 2019 | 60 | 0.690 |
Why?
|
| Parkinsonian Disorders | 2 | 2016 | 37 | 0.680 |
Why?
|
| Antiviral Agents | 1 | 2020 | 157 | 0.670 |
Why?
|
| Selenium | 1 | 2021 | 148 | 0.670 |
Why?
|
| Paraquat | 3 | 2023 | 21 | 0.660 |
Why?
|
| Neuroprotective Agents | 3 | 2024 | 245 | 0.650 |
Why?
|
| Computational Biology | 1 | 2021 | 293 | 0.650 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2019 | 88 | 0.650 |
Why?
|
| Ribonucleases | 7 | 2008 | 30 | 0.640 |
Why?
|
| Halogens | 1 | 2017 | 2 | 0.610 |
Why?
|
| Enzyme Assays | 1 | 2017 | 12 | 0.600 |
Why?
|
| Oxygen | 3 | 2024 | 207 | 0.600 |
Why?
|
| Drug Carriers | 1 | 2018 | 125 | 0.600 |
Why?
|
| Polymers | 1 | 2018 | 121 | 0.600 |
Why?
|
| Cysteine Endopeptidases | 1 | 2017 | 59 | 0.590 |
Why?
|
| Parkinson Disease | 3 | 2020 | 178 | 0.580 |
Why?
|
| Cell Line, Tumor | 8 | 2024 | 2231 | 0.570 |
Why?
|
| Antioxidants | 1 | 2020 | 416 | 0.560 |
Why?
|
| Peptide Fragments | 3 | 2016 | 308 | 0.560 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2018 | 173 | 0.530 |
Why?
|
| Trypanosoma cruzi | 1 | 2017 | 149 | 0.530 |
Why?
|
| Protozoan Proteins | 1 | 2017 | 182 | 0.520 |
Why?
|
| Nitric Oxide | 4 | 2015 | 316 | 0.520 |
Why?
|
| Lewy Bodies | 2 | 2016 | 30 | 0.520 |
Why?
|
| Reactive Nitrogen Species | 1 | 2014 | 9 | 0.500 |
Why?
|
| Models, Molecular | 6 | 2024 | 808 | 0.500 |
Why?
|
| Ethyl Methanesulfonate | 3 | 2005 | 7 | 0.470 |
Why?
|
| Electrons | 1 | 2013 | 68 | 0.450 |
Why?
|
| Gelatin | 2 | 2024 | 15 | 0.450 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 803 | 0.450 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 905 | 0.440 |
Why?
|
| Binding Sites | 3 | 2024 | 651 | 0.440 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2012 | 4 | 0.430 |
Why?
|
| Amino Acids | 1 | 2013 | 145 | 0.430 |
Why?
|
| Protein Denaturation | 7 | 2008 | 43 | 0.420 |
Why?
|
| Nitrates | 1 | 2012 | 40 | 0.420 |
Why?
|
| Circular Dichroism | 2 | 2024 | 62 | 0.390 |
Why?
|
| Benzylidene Compounds | 1 | 2010 | 5 | 0.380 |
Why?
|
| Protein Binding | 4 | 2024 | 972 | 0.380 |
Why?
|
| Piperidones | 1 | 2010 | 9 | 0.380 |
Why?
|
| Proteostasis Deficiencies | 2 | 2021 | 2 | 0.370 |
Why?
|
| Protein Structure, Tertiary | 4 | 2017 | 408 | 0.370 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 66 | 0.370 |
Why?
|
| Environmental Pollutants | 2 | 2023 | 179 | 0.370 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 61 | 0.360 |
Why?
|
| Drug Delivery Systems | 3 | 2023 | 202 | 0.350 |
Why?
|
| Stress, Physiological | 1 | 2010 | 150 | 0.340 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1015 | 0.330 |
Why?
|
| Green Fluorescent Proteins | 3 | 2016 | 208 | 0.320 |
Why?
|
| Peptide Mapping | 1 | 2008 | 19 | 0.320 |
Why?
|
| Neurons | 3 | 2022 | 1175 | 0.310 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2008 | 68 | 0.310 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 132 | 0.290 |
Why?
|
| Algorithms | 2 | 2016 | 465 | 0.280 |
Why?
|
| Ligands | 3 | 2017 | 349 | 0.270 |
Why?
|
| Drug Design | 3 | 2018 | 162 | 0.270 |
Why?
|
| Plastics | 1 | 2024 | 10 | 0.240 |
Why?
|
| Polystyrenes | 1 | 2024 | 19 | 0.240 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 2008 | 421 | 0.240 |
Why?
|
| Myoglobin | 1 | 2024 | 17 | 0.240 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2024 | 84 | 0.230 |
Why?
|
| Surface Properties | 1 | 2024 | 130 | 0.230 |
Why?
|
| Green Chemistry Technology | 1 | 2023 | 2 | 0.230 |
Why?
|
| Vitamin A | 1 | 2024 | 87 | 0.230 |
Why?
|
| Ionic Liquids | 1 | 2023 | 16 | 0.230 |
Why?
|
| Particle Size | 1 | 2024 | 215 | 0.230 |
Why?
|
| Thiazolidinediones | 1 | 2024 | 50 | 0.230 |
Why?
|
| Sulfhydryl Compounds | 1 | 2003 | 47 | 0.230 |
Why?
|
| Antimalarials | 1 | 2024 | 55 | 0.230 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2024 | 56 | 0.220 |
Why?
|
| Pesticides | 1 | 2023 | 52 | 0.220 |
Why?
|
| Thermodynamics | 4 | 2016 | 216 | 0.220 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2024 | 133 | 0.220 |
Why?
|
| Citric Acid | 1 | 2022 | 9 | 0.220 |
Why?
|
| Homeostasis | 1 | 2024 | 188 | 0.210 |
Why?
|
| Rodentia | 1 | 2022 | 43 | 0.210 |
Why?
|
| beta-Glucans | 1 | 2022 | 10 | 0.210 |
Why?
|
| Nitrosation | 2 | 2012 | 5 | 0.200 |
Why?
|
| Selenious Acid | 1 | 2021 | 3 | 0.200 |
Why?
|
| Bacillus | 1 | 2021 | 8 | 0.200 |
Why?
|
| Coal | 1 | 2021 | 10 | 0.200 |
Why?
|
| Structure-Activity Relationship | 3 | 2024 | 409 | 0.200 |
Why?
|
| Soil Pollutants | 1 | 2022 | 87 | 0.190 |
Why?
|
| Onions | 1 | 2021 | 7 | 0.190 |
Why?
|
| Biological Products | 1 | 2022 | 71 | 0.190 |
Why?
|
| Tissue Engineering | 1 | 2021 | 60 | 0.180 |
Why?
|
| Sequence Alignment | 2 | 2018 | 265 | 0.180 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2020 | 45 | 0.180 |
Why?
|
| Anticoagulants | 1 | 2021 | 102 | 0.180 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 49 | 0.180 |
Why?
|
| Prions | 1 | 2020 | 25 | 0.180 |
Why?
|
| Agriculture | 1 | 2020 | 56 | 0.180 |
Why?
|
| Chitosan | 1 | 2020 | 36 | 0.180 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2008 | 364 | 0.170 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 885 | 0.170 |
Why?
|
| Cell Proliferation | 2 | 2016 | 1198 | 0.170 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2018 | 15 | 0.170 |
Why?
|
| tau Proteins | 1 | 2020 | 167 | 0.160 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 162 | 0.160 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2018 | 47 | 0.160 |
Why?
|
| Recombinant Proteins | 3 | 2017 | 515 | 0.160 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2017 | 188 | 0.160 |
Why?
|
| Solvents | 1 | 2018 | 99 | 0.160 |
Why?
|
| Amino Acid Sequence | 2 | 2018 | 1180 | 0.160 |
Why?
|
| Biocompatible Materials | 1 | 2018 | 76 | 0.150 |
Why?
|
| Sulfur | 2 | 2016 | 18 | 0.150 |
Why?
|
| Databases, Protein | 2 | 2016 | 48 | 0.150 |
Why?
|
| Nucleic Acids | 1 | 2017 | 24 | 0.150 |
Why?
|
| Sulfur Compounds | 1 | 2016 | 7 | 0.150 |
Why?
|
| Protein Structure, Secondary | 1 | 2017 | 183 | 0.140 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 211 | 0.140 |
Why?
|
| Cytosol | 1 | 2016 | 93 | 0.140 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 131 | 0.140 |
Why?
|
| Picrates | 1 | 2016 | 8 | 0.140 |
Why?
|
| Chagas Disease | 1 | 2017 | 98 | 0.140 |
Why?
|
| Limonins | 1 | 2016 | 4 | 0.140 |
Why?
|
| Cell Line | 1 | 2020 | 1354 | 0.140 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2017 | 107 | 0.140 |
Why?
|
| Isomerism | 2 | 2008 | 63 | 0.140 |
Why?
|
| Biphenyl Compounds | 1 | 2016 | 53 | 0.140 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 218 | 0.130 |
Why?
|
| Phenylenediamines | 1 | 2015 | 8 | 0.130 |
Why?
|
| Cyclohexylamines | 1 | 2015 | 12 | 0.130 |
Why?
|
| Proteomics | 1 | 2018 | 325 | 0.130 |
Why?
|
| Guanidine | 3 | 2004 | 13 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 187 | 0.130 |
Why?
|
| Transfection | 1 | 2016 | 523 | 0.130 |
Why?
|
| Cysteine | 3 | 2005 | 98 | 0.130 |
Why?
|
| Flow Cytometry | 1 | 2016 | 399 | 0.130 |
Why?
|
| Cell Nucleolus | 1 | 2014 | 9 | 0.130 |
Why?
|
| Brain | 1 | 2022 | 1346 | 0.120 |
Why?
|
| PC12 Cells | 1 | 2014 | 93 | 0.120 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 78 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 111 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 893 | 0.120 |
Why?
|
| Neoplasms | 3 | 2018 | 1103 | 0.120 |
Why?
|
| Azadirachta | 1 | 2013 | 3 | 0.120 |
Why?
|
| Dopamine | 1 | 2015 | 245 | 0.120 |
Why?
|
| Organoplatinum Compounds | 2 | 2003 | 16 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2018 | 269 | 0.110 |
Why?
|
| Plant Leaves | 1 | 2013 | 124 | 0.110 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2013 | 70 | 0.110 |
Why?
|
| Nitrogen | 1 | 2013 | 71 | 0.110 |
Why?
|
| Enzyme Stability | 3 | 2007 | 35 | 0.110 |
Why?
|
| Mitochondrial Diseases | 1 | 2012 | 16 | 0.110 |
Why?
|
| Necrosis | 1 | 2012 | 49 | 0.110 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 77 | 0.100 |
Why?
|
| Caspases | 1 | 2012 | 147 | 0.100 |
Why?
|
| Rana pipiens | 3 | 2007 | 62 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2013 | 286 | 0.090 |
Why?
|
| Flavonoids | 1 | 2010 | 87 | 0.090 |
Why?
|
| Mice | 2 | 2022 | 5913 | 0.090 |
Why?
|
| Rats | 2 | 2014 | 3483 | 0.090 |
Why?
|
| Phenols | 1 | 2010 | 80 | 0.090 |
Why?
|
| Aged | 2 | 2020 | 6741 | 0.090 |
Why?
|
| Biochemical Phenomena | 1 | 2009 | 2 | 0.090 |
Why?
|
| Food Chain | 1 | 2009 | 16 | 0.090 |
Why?
|
| Metals, Heavy | 1 | 2009 | 60 | 0.080 |
Why?
|
| Complex Mixtures | 1 | 2008 | 8 | 0.080 |
Why?
|
| Time Factors | 3 | 2007 | 1742 | 0.080 |
Why?
|
| Plants | 1 | 2009 | 99 | 0.080 |
Why?
|
| Drug Utilization Review | 1 | 2007 | 7 | 0.080 |
Why?
|
| Hospital Information Systems | 1 | 2007 | 6 | 0.080 |
Why?
|
| Organic Chemicals | 1 | 2007 | 35 | 0.080 |
Why?
|
| Peptides, Cyclic | 1 | 2007 | 29 | 0.070 |
Why?
|
| Pediatrics | 1 | 2007 | 68 | 0.070 |
Why?
|
| Oligosaccharides | 1 | 2005 | 24 | 0.070 |
Why?
|
| Methylamines | 1 | 2004 | 12 | 0.060 |
Why?
|
| Lactalbumin | 1 | 2004 | 6 | 0.060 |
Why?
|
| Phosphatidylserines | 1 | 2004 | 21 | 0.060 |
Why?
|
| Transition Temperature | 1 | 2003 | 8 | 0.060 |
Why?
|
| Cyclic N-Oxides | 1 | 2004 | 18 | 0.060 |
Why?
|
| Dithioerythritol | 1 | 2003 | 1 | 0.060 |
Why?
|
| Membranes, Artificial | 1 | 2004 | 28 | 0.060 |
Why?
|
| Phosphatidylcholines | 1 | 2004 | 47 | 0.060 |
Why?
|
| Administration, Cutaneous | 1 | 2023 | 43 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 201 | 0.060 |
Why?
|
| Triazoles | 1 | 2024 | 86 | 0.060 |
Why?
|
| Indoles | 1 | 2024 | 158 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2018 | 130 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 33 | 0.050 |
Why?
|
| Biodegradation, Environmental | 1 | 2022 | 80 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2024 | 492 | 0.050 |
Why?
|
| Male | 1 | 2021 | 20025 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2022 | 224 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 260 | 0.050 |
Why?
|
| Ecosystem | 1 | 2022 | 123 | 0.050 |
Why?
|
| Soil | 1 | 2022 | 130 | 0.050 |
Why?
|
| Calcium | 1 | 2004 | 480 | 0.050 |
Why?
|
| Agrochemicals | 1 | 2020 | 4 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 352 | 0.050 |
Why?
|
| Crops, Agricultural | 1 | 2020 | 31 | 0.050 |
Why?
|
| Models, Biological | 1 | 2003 | 677 | 0.040 |
Why?
|
| Liver | 1 | 2022 | 479 | 0.040 |
Why?
|
| Vertebrates | 1 | 2018 | 29 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2018 | 61 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2018 | 119 | 0.040 |
Why?
|
| Anemia | 1 | 2018 | 45 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 27 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2018 | 83 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2018 | 212 | 0.040 |
Why?
|
| Forecasting | 1 | 2018 | 128 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 2018 | 67 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2018 | 70 | 0.040 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2016 | 10 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 213 | 0.040 |
Why?
|
| Static Electricity | 1 | 2016 | 78 | 0.040 |
Why?
|
| Trypsin | 2 | 2008 | 38 | 0.030 |
Why?
|
| Adenine | 1 | 2016 | 44 | 0.030 |
Why?
|
| Plasmodium falciparum | 1 | 2016 | 135 | 0.030 |
Why?
|
| Autophagy | 1 | 2016 | 116 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 219 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2018 | 517 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 169 | 0.030 |
Why?
|
| Methylnitrosourea | 1 | 2013 | 2 | 0.030 |
Why?
|
| Bacteria | 1 | 2016 | 255 | 0.030 |
Why?
|
| Phytotherapy | 1 | 2013 | 81 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 540 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 1618 | 0.020 |
Why?
|
| Anura | 1 | 2008 | 32 | 0.020 |
Why?
|
| Computer Communication Networks | 1 | 2007 | 13 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2007 | 20 | 0.020 |
Why?
|
| Drug Therapy | 1 | 2007 | 17 | 0.020 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2007 | 7 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 144 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2007 | 291 | 0.020 |
Why?
|
| Internet | 1 | 2007 | 211 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2005 | 161 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2004 | 13 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2007 | 894 | 0.020 |
Why?
|
| Entropy | 1 | 2004 | 13 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 295 | 0.020 |
Why?
|
| Spin Labels | 1 | 2004 | 9 | 0.010 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2004 | 39 | 0.010 |
Why?
|
| Chymotrypsin | 1 | 2003 | 15 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2003 | 25 | 0.010 |
Why?
|
| Infant | 1 | 2007 | 1046 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2003 | 98 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 132 | 0.010 |
Why?
|
| Lipid Bilayers | 1 | 2004 | 68 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2007 | 1418 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2004 | 207 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 433 | 0.010 |
Why?
|
| Phosphines | 1 | 2002 | 6 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 562 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 2379 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 935 | 0.010 |
Why?
|
| Child | 1 | 2007 | 3131 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 5363 | 0.010 |
Why?
|
| Female | 1 | 2013 | 20969 | 0.010 |
Why?
|
| Middle Aged | 1 | 2007 | 10129 | 0.010 |
Why?
|
| Adult | 1 | 2007 | 11712 | 0.010 |
Why?
|